Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078504 · ClinicalTrials.gov registry record · NA
Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy
A NA study, sponsored by St. Louis University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03078504: Clinical Trial NA study, sponsored by St. Louis University.
NCT03078504 is a NA study that was terminated before completion, run by St. Louis University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03078504, a NA study, was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Purpose of this study is to evaluate the short-term hemodynamic effects of changes in blood flow rates in critically ill patients receiving continuous renal replacement therapy.
Primary Outcome
Change in mean arterial pressure from period 1 to period 2
Interventions
- DEVICE continuous renal replacement therapy using System One (TM) setup (Nxstage)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
Why NCT03078504 stopped before completion
NCT03078504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which continuous renal replacement therapy using System One (TM) setup (Nxstage) is the first listed.
NCT03078504 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03078504 about?
NCT03078504 is a clinical study titled "Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy". Purpose of this study is to evaluate the short-term hemodynamic effects of changes in blood flow rates in critically ill patients receiving continuous renal replacement therapy.
What is the current status of trial NCT03078504?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2017-02-17. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03078504?
The interventions under investigation include: continuous renal replacement therapy using System One (TM) setup (Nxstage) (DEVICE).
Who is sponsoring clinical trial NCT03078504?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03078504's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI